Further studies using endobronchial tissue biopsies from patients with COPD are needed to confirm the in vitro data presented in this study and to elucidate under which clinical conditions the anti-inflammatory effect of eHSPs will counterbalance the pro-inflammatory effect of TLR4. This evidence concerns the gene TLR4 and chronic obstructive pulmonary disease.